BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 30729667)

  • 1. Flow Cytometry Applications in the Diagnosis of T/NK-Cell Lymphoproliferative Disorders.
    Jevremovic D; Olteanu H
    Cytometry B Clin Cytom; 2019 Mar; 96(2):99-115. PubMed ID: 30729667
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The immunophenotypic attributes of NK cells and NK-cell lineage lymphoproliferative disorders.
    Morice WG
    Am J Clin Pathol; 2007 Jun; 127(6):881-6. PubMed ID: 17509985
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flow cytometric immunophenotyping is of great value to diagnosis of natural killer cell neoplasms involving bone marrow and peripheral blood.
    Jiang NG; Jin YM; Niu Q; Zeng TT; Su J; Zhu HL
    Ann Hematol; 2013 Jan; 92(1):89-96. PubMed ID: 22992980
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnosis of chronic lymphoproliferative disorders by flow cytometry using four-color combinations for immunophenotyping: A proposal of the brazilian group of flow cytometry (GBCFLUX).
    Sales MM; Ferreira SIACP; Ikoma MRV; Sandes AF; Beltrame MP; Bacal NS; Silva MCA; Malvezzi M; Lorand-Metze IGH; Orfao A; Yamamoto M;
    Cytometry B Clin Cytom; 2017 Sep; 92(5):398-410. PubMed ID: 27362793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Natural killer-type receptors for HLA class I antigens are clonally expressed in lymphoproliferative disorders of natural killer and T-cell type.
    Hoffmann T; De Libero G; Colonna M; Wodnar-Filipowicz A; Passweg J; Favre G; Gratwohl A; Tichelli A
    Br J Haematol; 2000 Sep; 110(3):525-36. PubMed ID: 10997961
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phenotypic profile of expanded NK cells in chronic lymphoproliferative disorders: a surrogate marker for NK-cell clonality.
    Bárcena P; Jara-Acevedo M; Tabernero MD; López A; Sánchez ML; García-Montero AC; Muñoz-García N; Vidriales MB; Paiva A; Lecrevisse Q; Lima M; Langerak AW; Böttcher S; van Dongen JJ; Orfao A; Almeida J
    Oncotarget; 2015 Dec; 6(40):42938-51. PubMed ID: 26556869
    [TBL] [Abstract][Full Text] [Related]  

  • 7. T- and NK-cell lymphoproliferative disorders of the gastrointestinal tract: review and update.
    van Vliet C; Spagnolo DV
    Pathology; 2020 Jan; 52(1):128-141. PubMed ID: 31727264
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug resistance in aggressive lymphoproliferative disorders of T and natural-killer origin.
    Drénou B; Amiot L; Lamy T; Le Prisé PY; Fauchet R
    Leuk Lymphoma; 1998 Jul; 30(3-4):381-7. PubMed ID: 9713968
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorders.
    Cai Q; Chen K; Young KH
    Exp Mol Med; 2015 Jan; 47(1):e133. PubMed ID: 25613730
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of monoclonal T populations in patients with KIR-restricted chronic lymphoproliferative disorder of NK cells.
    Gattazzo C; Teramo A; Passeri F; De March E; Carraro S; Trimarco V; Frezzato F; Berno T; Barilà G; Martini V; Piazza F; Trentin L; Facco M; Semenzato G; Zambello R
    Haematologica; 2014 Dec; 99(12):1826-33. PubMed ID: 25193965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric assessment of T-cell chronic lymphoproliferative disorders.
    Cady FM; Morice WG
    Clin Lab Med; 2007 Sep; 27(3):513-32, vi. PubMed ID: 17658405
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pulmonary infiltration as the initial manifestation of chronic lymphoproliferative disorder of natural killer cells: a case report and literature review.
    Zhang J; Wang P; Yan X
    BMC Pulm Med; 2021 Mar; 21(1):94. PubMed ID: 33740949
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristic expansion of CD45RA CD27 CD28 CCR7 lymphocytes with stable natural killer (NK) receptor expression in NK- and T-cell type lymphoproliferative disease of granular lymphocytes.
    Mitsui T; Maekawa I; Yamane A; Ishikawa T; Koiso H; Yokohama A; Handa H; Matsushima T; Tsukamoto N; Murakami H; Nojima Y; Karasawa M
    Br J Haematol; 2004 Jul; 126(1):55-62. PubMed ID: 15198732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential diagnosis of T-cell lymphoproliferative disorders by flow cytometry multicolor immunophenotyping. correlation with morphology.
    Gorczyca W
    Methods Cell Biol; 2004; 75():595-621. PubMed ID: 15603444
    [No Abstract]   [Full Text] [Related]  

  • 15. Chronic lymphoproliferative disorder of NK-cells: A single-institution review with emphasis on relative utility of multimodality diagnostic tools.
    Kurt H; Jorgensen JL; Amin HM; Patel KP; Wang SA; Lin P; Kanagal-Shamanna R; Loghavi S; Thakral B; Khogeer HA; Jabbour EJ; Li S; Yin CC; Medeiros LJ; Khoury JD
    Eur J Haematol; 2018 May; 100(5):444-454. PubMed ID: 29385279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A practical approach to the flow cytometric detection and diagnosis of T-cell lymphoproliferative disorders.
    Meyerson HJ
    Lab Hematol; 2010 Sep; 16(3):32-52. PubMed ID: 20858587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comprehensive Flow-Cytometry-Based Immunophenotyping Analysis for Accurate Diagnosis and Management of Extranodal NK/T Cell Lymphoma, Nasal Type.
    Wang JC; Deng XQ; Liu WP; Gao LM; Zhang WY; Yan JQ; Ye YX; Liu F; Zhao S
    Cytometry B Clin Cytom; 2020 Jan; 98(1):28-35. PubMed ID: 31313887
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-CCR4 monoclonal antibody mogamulizumab for the treatment of EBV-associated T- and NK-cell lymphoproliferative diseases.
    Kanazawa T; Hiramatsu Y; Iwata S; Siddiquey M; Sato Y; Suzuki M; Ito Y; Goshima F; Murata T; Kimura H
    Clin Cancer Res; 2014 Oct; 20(19):5075-84. PubMed ID: 25117294
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Flow Cytometry for Non-Hodgkin and Hodgkin Lymphomas.
    Glynn E; Soma L; Wu D; Wood BL; Fromm JR
    Methods Mol Biol; 2019; 1956():35-60. PubMed ID: 30779029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow Cytometric Immunophenotyping Is Sensitive for the Early Diagnosis of De Novo Aggressive Natural Killer Cell Leukemia (ANKL): A Multicenter Retrospective Analysis.
    Li Y; Wei J; Mao X; Gao Q; Liu L; Cheng P; Liu L; Zhang X; Zhang K; Wang J; Zhu L; Zhou J; Zhang Y; Meng L; Sun H; Li D; Huang M; Huang W; Deng J; Zhang D
    PLoS One; 2016; 11(8):e0158827. PubMed ID: 27483437
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.